Sign up to save your podcasts
Or
Share E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
Fun study this week from JAMA Network Open and the French Vasculitis Study Group. They used a target trial emulation (one of my favorites) to ask whether RTX > CYC in AAV (another one of my favorites). I tried to use this to compare between observational and randomized data.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799018
View all episodes
By Michael Putman
4.9
113113 ratings
Fun study this week from JAMA Network Open and the French Vasculitis Study Group. They used a target trial emulation (one of my favorites) to ask whether RTX > CYC in AAV (another one of my favorites). I tried to use this to compare between observational and randomized data.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799018
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
323 Listeners
JAMA Clinical Reviews
498 Listeners
This Week in Cardiology
878 Listeners
Rheumnow Podcast
131 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Healio Rheuminations
121 Listeners
Annals On Call Podcast
191 Listeners
Freely Filtered, a NephJC Podcast
172 Listeners
ACR on Air
67 Listeners
Run the List
247 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
Rheumatology For The Royal College
183 Listeners
RheumMadness Rheumatology Podcast
11 Listeners
ACR Journals On Air
18 Listeners
Talking Rheumatology Spotlight
6 Listeners